Desprescribing benzodiazepine protocol.

Phase 4

Recruiting

• Conditions: Chemically-Induced Disorders; Substance-Related Disorders; Medication Errors; C25.775; E02.319.529

• Registration Number: RBR-8hr69v
• Lead Sponsor: niversidade Federal de São João del-Rei

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-09-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

First stage: medical professionals, nurses and pharmacists with clinical and/or academic experience in the care of the elderly will be included. For analysis of the understanding of the content of the messages will be included seniors who are 60 years or older, who can read and who do not use benzodizepines;
Second and third stages: Elderly will be included from all units in the urban area of the municipality in chronic use of benzodiazepines for anxiety and insomnia, administered daily for at least three months, which were attended in one of the ESF.

Exclusion Criteria

Patients who use benzodiazepines for the treatment of epilepsy, psychiatric illness with a history of psychosis and alcohol and illegal drug addicts will be excluded; patients who are not cognitively competent, according to the mini-mental state examination - MEEM-23.

Study & Design

• Study Type: Intervention
• Study Design: Not specified